Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4398)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 26, 2024 (publication date) through Nov 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial. World J Stem Cells 2024; 16(12): 1012-1021 [PMID: 39734483 DOI: 10.4252/wjsc.v16.i12.1012] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial. World J Stem Cells 2024; 16(12): 1012-1021 [PMID: 39734483 DOI: 10.4252/wjsc.v16.i12.1012] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v16/i12/1012.htm |
| Number | Citing Articles |
| 1 |
Takayasu Ohtake, Amankeldi A. Salybekov, Tsutomu Sato, Shigeaki Okamura, Masaki Yazawa, Yuki Yano, Mehdi Hassanpour, Mitsuru Yanai, Makoto Imagawa, Takayuki Asahara, Shuzo Kobayashi. Efficacy of Repeated Administration of Cultured Human CD34+ Cells Against Streptozotocin-Induced Diabetic Nephropathy in Rats. Cells 2025; 14(22): 1766 doi: 10.3390/cells14221766
|